ClearPoint Neuro Reports Q3 Revenue of USD 12.1 Million
ClearPoint Neuro reported Q3 gross margin of 58%.
Related stories
LKQ halts strategic review and extends buyback program
LKQ shares rose as the company halted its strategic review and extended its buyback program.
M impact | EQUITY | Oct 29, 2026, 01:40 PM UTC
Anhui Kouzi Distillery Q3 Net Profit Falls 28.41% YoY
M impact | EQUITY | Oct 29, 2026, 01:25 PM UTC
Lovisagruvan Reports Third-Quarter 2026 Results
Lovisagruvan AB issued its third-quarter 2026 report. The supplied excerpt says the quarter focused on continued development work.
M impact | EQUITY | Oct 29, 2026, 01:25 PM UTC
Afcons Infrastructure Secures Two Uttar Pradesh EPC Contracts Worth 34.69 Billion Rupees
M impact | EQUITY | Oct 29, 2026, 01:25 PM UTC
Capital Small Finance Bank Reports Q2 Net Profit of 456.1 Million Rupees
M impact | EQUITY | Oct 29, 2026, 01:24 PM UTC
NTPC Vidyut Vypar Nigam Declares 250 MW / 500 MWh BESS Project Commercial
M impact | EQUITY | Oct 29, 2026, 01:23 PM UTC